Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma

Abstract High-risk neuroblastoma (HR-NB) has a significantly lower survival rate compared to low- and intermediate-risk NB (LIR-NB) due to the lack of risk classification diagnostic models and effective therapeutic targets. The present study aims to characterize the differences between neuroblastoma...

Full description

Bibliographic Details
Main Authors: Bang Du, Fei Zhang, Qiumei Zhou, Weyland Cheng, Zhidan Yu, Lifeng Li, Jianwei Yang, Xianwei Zhang, Chongchen Zhou, Wancun Zhang
Format: Article
Language:English
Published: Nature Portfolio 2023-10-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-43988-w